Medicine and Dentistry
Acute Pulmonary Embolism
100%
Pulmonary Embolism
96%
Heart Right Ventricle Failure
39%
Lung Vascular Resistance
36%
Pulmonary Embolism Response Team
30%
Right Ventricular Function
27%
Lung Artery Pressure
24%
Pulmonary Artery
24%
Sildenafil
23%
Hemodynamic
22%
Right Ventricular Hypertrophy
20%
Levosimendan
20%
Nitric Oxide
20%
Afterload
18%
Blood Clot Lysis
15%
Vasodilatation
14%
Peripheral Vasodilating Agent
14%
Pulmonary Angiography
13%
Heart Output
12%
Vascular Occlusion
12%
Obstruction
12%
Computer Assisted Tomography
11%
Systolic Blood Pressure
11%
Stroke Volume
11%
Heart Preload
10%
Milrinone
10%
Fibrinolytic Therapy
10%
Exhaled Breath Condensate
10%
Protein Analysis
10%
Riociguat
10%
Pulmonary Hypertension
10%
Dobutamine
10%
Terlipressin
10%
Mass Spectrum
10%
Chronic Thromboembolic Pulmonary Hypertension
10%
Embolism
9%
Diuretic Agent
8%
Blood Pressure
7%
Ventricular Tachycardia
7%
Hypoxia
6%
Diagnosis
6%
Cardiac Catheterization
6%
Ejection Fraction
6%
Semaxanib
5%
Mean Arterial Pressure
5%
Heart Right Ventricle Function
5%
Adverse Event
5%
Adverse Outcome
5%
Heart Ventricle Overload
5%
Placebo
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Embolism
61%
Heart Right Ventricle Failure
32%
Biological Marker
15%
Heart Right Ventricle Hypertrophy
15%
Porcine Model
15%
Peripheral Vasodilating Agent
13%
Obstruction
13%
Pig
11%
Losartan
10%
Bisoprolol
10%
Protein Characterization
10%
Nitric Oxide
10%
Terlipressin
10%
Pulmonary Hypertension
10%
Levosimendan
10%
Chronic Thromboembolic Pulmonary Hypertension
10%
Embolism
8%
Hypoxia
5%
Semaxanib
5%
Heart Ventricle Overload
5%
Keyphrases
Team Experience
10%
Pulmonary Embolism Response Team
10%
Right Heart Hemodynamics
10%
Right Ventricular Adaptation
10%
High-risk Pulmonary Embolism
10%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
10%
Pulmonary Artery Systolic Pressure
10%
Pulmonary Artery
10%
Right Ventricular
10%
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
10%
Pressure Ratio
6%
Rheolytic
5%
Catheter-directed Thrombolysis
5%
Pulmonary Vascular Resistance
5%
